SCHEMBL18392428

SCHEMBL18392428

COc1ccc2[nH]cc(-c3c(-c4c(-c5ccccc5)[nH]c5ccccc45)c(=O)c3=O)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 1/20 0.52
▸ ALDH1A1 P00352 3/20 0.48
▸ HPGD P15428 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ MTNR1A P48039 2/20 0.47
▸ MTNR1B P49286 2/20 0.47
▸ GPR84 Q9NQS5 1/20 0.46
▸ TUBB4A P04350 2/20 0.46
▸ TUBB P07437 2/20 0.46
▸ TUBA3C P0DPH7 2/20 0.46
▸ TUBA1B P68363 2/20 0.46
▸ TUBA4A P68366 2/20 0.46
▸ TUBB4B P68371 2/20 0.46
▸ TUBB3 Q13509 2/20 0.46
▸ TUBB2A Q13885 2/20 0.46
▸ TUBB8 Q3ZCM7 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18392173 0.87 ABCG2 (0.54) ABCG2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL18392204 0.86 ABCG2 (0.57) ABCG2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL18392164 0.85 ESR1 (0.54) ALDH1A1HPGDHSD17B10MEN1MAPT
SCHEMBL18392216 0.83 PTGS2 (0.48) ALDH1A1HPGDKDM4EMEN1MAPT
SCHEMBL18392172 0.82 PDE4B (0.59) ALDH1A1HPGDKDM4EHSD17B10MEN1
SCHEMBL20365539 0.80 ESR1 (0.42) HPGDGPR84PTGS2
SCHEMBL3333256 0.79 MEN1 (0.50) ABCG2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL18392199 0.78 PDE4B (0.52) ALDH1A1KDM4EHSD17B10MEN1MAPT
SCHEMBL7262282 0.77 ABCG2 (0.55) ABCG2ALDH1A1HPGDKDM4EMEN1
SCHEMBL19717689 0.77 DYRK1A (0.63) ALDH1A1HPGDKDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3319940-B1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME UNIV BRAUNSCHWEIG TECH (DE) 2019-05-29 — — EP disclosed
EP-3319940-B1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME UNIV BRAUNSCHWEIG TECH (DE) 2019-05-29 — — EP disclosed
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2019-05-14 — — US disclosed
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2019-05-14 — — US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 — — US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 — — US disclosed
WO-2017008826-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2017-01-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME IDO1, IDO2, INMT ABCG2 354/4885ALDH1A1 774/4885HPGD 140/4885
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same IDO1, IDO2, INMT ABCG2 551/4885ALDH1A1 638/4885HPGD 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback